Located at 45 Rivington Street 5th Floor in New York, New York, Mount Sinai Beth Israel Medical Center – CD Inpatient Detox is a nonprofit addiction treatment provider. The CD Inpatient Detox program is operated by Mount Sinai Beth Israel Medical Center.
Its services include detox (medically supervised withdrawal), hospital inpatient care, medication-assisted treatment (MAT), and co-occurring (dual diagnosis) mental health treatment. Clinicians use approaches such as anger management, brief intervention, cognitive behavioral therapy, motivational interviewing, and relapse prevention. For opioid use disorder, the program uses buprenorphine and naltrexone. It also prescribes medication for alcohol use disorder.
Mount Sinai Beth Israel Medical Center – CD Inpatient Detox accepts IHS/Tribal/Urban (ITU) funds, Medicare, Medicaid, military insurance (TRICARE), private health insurance, cash or self-payment, and state-financed health insurance plan other than Medicaid. A sliding fee scale based on income is available. Coverage depends on your specific plan, so verify benefits before admission.
The program accepts young adults, adults, and seniors. It offers specialized groups for clients with co-occurring mental and substance use disorders. Services are available in Spanish. Sign language services are available for deaf and hard-of-hearing clients.
Mount Sinai Beth Israel Medical Center – CD Inpatient Detox is accredited by The Joint Commission and licensed or certified by the state substance use treatment agency and drug Enforcement Agency (DEA).
Support services include aftercare/continuing care, discharge planning, naloxone and overdose education, and self-help groups.